Allogene Therapeutics (ALLO) Current Deferred Revenue (2020 - 2024)
Allogene Therapeutics' Current Deferred Revenue came in at $86,000 for Q1 2024, unchanged from $86,000 a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Allogene Therapeutics (ALLO) Current Deferred Revenue (2020 - 2024) Analysis & Trends
Going back to Q4 2020, Allogene Therapeutics' Current Deferred Revenue data covers 14 quarters.
- Current Deferred Revenue has declined in each of the last three years, with a three-year compound annual growth rate of -87.0% (FY2020 to FY2023).
- Going back by year, Current Deferred Revenue was $95,000 in FY2022 (-39.1%), $156,000 in FY2021 (-99.6%) and $38.99 million in FY2020.
- The five-year range for quarterly Current Deferred Revenue is $86,000 (Q1 2023) to $38.99 million (Q4 2020).
- Over the past five years, the year-over-year decline in Current Deferred Revenue ranged from 0.0% (Q1 2024) to 99.6% (Q4 2021).
- Business Quant data shows ALLO's Current Deferred Revenue at $86,000 (Q4 2023), $86,000 (Q3 2023) and $86,000 (Q2 2023) in the three quarters before Q1 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn |
| 10 | Allogene Therapeutics | 435.17 Mn | -666.72 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2024 | 86,000.00 |
| Dec 31, 2023 | 86,000.00 |
| Sep 30, 2023 | 86,000.00 |
| Jun 30, 2023 | 86,000.00 |
| Mar 31, 2023 | 86,000.00 |
| Dec 31, 2022 | 95,000.00 |
| Sep 30, 2022 | 99,000.00 |
| Jun 30, 2022 | 104,000.00 |
| Mar 31, 2022 | 147,000.00 |
| Dec 31, 2021 | 156,000.00 |
| Sep 30, 2021 | 365,000.00 |
| Jun 30, 2021 | 305,000.00 |
| Mar 31, 2021 | 239,000.00 |
| Dec 31, 2020 | 38.99 Mn |
API Access
Allogene Therapeutics Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=ALLO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "ALLO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=ALLO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();